These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21340573)

  • 1. Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells.
    Zhang Y; Wang X; Wang J; Zhang X; Zhang Q
    Pharm Res; 2011 May; 28(5):1167-78. PubMed ID: 21340573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study.
    Li Y; Yang F; Chen W; Liu J; Huang W; Jin M; Gao Z
    Chem Pharm Bull (Tokyo); 2012; 60(9):1146-54. PubMed ID: 22976323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
    Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
    Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.
    Jaskula-Sztul R; Xu W; Chen G; Harrison A; Dammalapati A; Nair R; Cheng Y; Gong S; Chen H
    Biomaterials; 2016 Jun; 91():1-10. PubMed ID: 26994874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
    Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
    Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-interactive mPEG-
    Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
    Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells.
    Wang X; Wang Y; Chen X; Wang J; Zhang X; Zhang Q
    J Control Release; 2009 Oct; 139(1):56-62. PubMed ID: 19470394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
    Huo M; Zou A; Yao C; Zhang Y; Zhou J; Wang J; Zhu Q; Li J; Zhang Q
    Biomaterials; 2012 Sep; 33(27):6393-407. PubMed ID: 22704599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
    Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
    Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro evaluation of a pH-sensitive PLA-PEG-folate based polymeric micelle for controlled delivery of docetaxel.
    Hami Z; Amini M; Ghazi-Khansari M; Rezayat SM; Gilani K
    Colloids Surf B Biointerfaces; 2014 Apr; 116():309-17. PubMed ID: 24503352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a docetaxel micellar formulation using poly(ethylene glycol)-polylactide-poly(ethylene glycol) (PEG-PLA-PEG) with successful reconstitution for tumor targeted drug delivery.
    Sim T; Kim JE; Hoang NH; Kang JK; Lim C; Kim DS; Lee ES; Youn YS; Choi HG; Han HK; Weon KY; Oh KT
    Drug Deliv; 2018 Nov; 25(1):1362-1371. PubMed ID: 29869563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of PLLA-PEG and PDLLA-PEG micelles for co-encapsulation of docetaxel and resveratrol.
    Jurczyk M; Musiał-Kulik M; Foryś A; Godzierz M; Kaczmarczyk B; Kasperczyk J; Wrześniok D; Beberok A; Jelonek K
    J Biomed Mater Res B Appl Biomater; 2024 Jan; 112(1):e35318. PubMed ID: 37650461
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
    Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of octreotide-modified curcumin plus docetaxel micelles for potential treatment of non-small-cell lung cancer.
    An Q; Shi CX; Guo H; Xie SM; Yang YY; Liu YN; Liu ZH; Zhou CZ; Niu FJ
    Pharm Dev Technol; 2019 Nov; 24(9):1164-1174. PubMed ID: 31340709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer.
    Mei D; Zhao L; Chen B; Zhang X; Wang X; Yu Z; Ni X; Zhang Q
    Drug Deliv; 2018 Nov; 25(1):493-503. PubMed ID: 29426250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.